Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $44.76M in the quarter ending September 30, 2024, with 17.44% growth. This brings the company's revenue in the last twelve months to $138.71M, up 182.84% year-over-year. In the year 2023, Arcutis Biotherapeutics had annual revenue of $59.61M with 1,517.09% growth.

• Revenue (ttm): $138.71M
• Revenue Growth: +182.84%
• P/S Ratio: 10.32
• Revenue / Employee: $468,608
• Employees: 296
• Market Cap: 1.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.